National Match Code: 635260

PGY2 Oncology Program Director
Emma Carroll, PharmD, BCOP
Telephone: 414-805-3145
E-mail: [email protected]

PGY2 Oncology Program Coordinator
Stephanie Spitzer, PharmD, BCOP
E-mail: [email protected]

Duration/Type: 12-month residency
Number of Positions: 4
Application Deadline: Jan. 2, 2024
Starting Date: July 1, 2024
Stipend: $53,040

Residency Manual

PGY2 Oncology Preceptors

The purpose of this PGY2 pharmacy residency program is to build on Doctor of Pharmacy (PharmD) education and PGY1 pharmacy residency programs to contribute to the development of clinical pharmacists in specialized areas of practice. PGY2 residencies provide residents with opportunities to function independently as practitioners by conceptualizing and integrating accumulated experience and knowledge and incorporating both into the provision of patient care or other advanced practice settings. Residents who successfully complete an accredited PGY2 pharmacy residency are prepared for advanced patient care, academic, or other specialized positions, along with board certification.


This specialty residency is designed to provide advanced clinical training in oncology and leadership development opportunities. Upon completion of the residency, the graduates’ advanced knowledge and leadership skills will enable them to practice as an integral member of an interdisciplinary team in the care of the oncology patient, engage in clinical instructor/precepting opportunities and they will be prepared to attain board certification (BCOP).

Flexible, comprehensive training in both acute care and ambulatory oncology settings with a focus on multidisciplinary collaboration.

  • Rotations and activities are tailored to meet the needs and interests of each resident.
  • Year-long research projects are expected to be submitted for publication.
  • Residents will have the opportunity to precept PGY1 pharmacy residents and PharmD students on clinical rotations.

Requirements for Acceptance

  • Completion of PGY1 pharmacy residency
  • Applicants are required to submit a program application through PhORCAS. Please follow the application instructions.

Learning Experiences

Required Rotations

  • Inpatient Rotations
    • Inpatient Acute Care Oncology (2 – 3 weeks)
    • Inpatient Hematologic Malignancies (4 weeks)
    • Inpatient Blood and Marrow Transplant (4 weeks)
  • Ambulatory Care
    • Hematology/Blood and Marrow transplant (Grace Clinic – 4 weeks)
    • Gastrointestinal Malignancies (Faith Clinic – 2 weeks)
    • Gynecology and Thoracic Malignancies (Courage Clinic – 2 weeks)
    • Breast Cancer (Breast Care Clinic – 2 weeks)
    • Genitourinary and Sarcoma Malignancies (Life Clinic – 2 weeks)
  • Head & Neck, Central Nervous System, Skin, and Endocrine Malignancies (Hope Clinic – 2 weeks)
  • Investigational Drug Service (3 weeks)
  • Longitudinal Experiences
    • Drug Policy (Collaboration with Oncology Pharmacy & Therapeutics Subcommittee – 3 weeks)
    • Multidisciplinary Collaboration (Collaboration with Oncology Pharmacy & Nursing Committee and Molecular Tumor Board – 3 weeks)
    • Pharmacogenomics (Collaboration with Molecular Tumor Board – 3 weeks)
    • Medication Safety and Leadership (Medication Error Review and Reporting – 3 weeks)
  • Longitudinal Research Project (12 months)
  • Weekly Oncology Residency Discussion (WORDs) (12 months)

Elective Rotations

  • Academia Advanced (2 – 4 weeks)
  • Infectious Disease (2 – 4 weeks)
  • Pharmacy Informatics (3 – 4 weeks)
  • Critical Care Oncology (2 – 4 weeks)
  • Advanced Practice Oncology (2 – 4 weeks)
  • Pediatric Oncology (Children’s Hospital of Wisconsin – 3 – 4 weeks)
  • Specialty Pharmacy – Oncology (2 – 4 weeks)

Opportunities for elective experiences that could be developed based on interest include: oncology pain stewardship, oncology palliative care, oncology medical writing, oncology leadership

Requirements and Expectations

In addition to requirements for individual learning experiences, satisfactory completion of the below list is required to earn a Froedtert Hospital PGY2 Oncology Residency certificate. Pharmacy residents are required to be licensed in the state of Wisconsin within 90 days of start date with the Froedtert & MCW health network.

Clinical and Operations Practice (On-Site Staffing) Requirements

  • Includes weekend shifts, weekday shifts (Mon-Fri), holiday shifts, and up to four additional weekday shifts.
    • Staffing is prioritized to be staffed in oncology areas; however, residents may be assigned or volunteer for non-oncology shifts as available in cross-trained areas
    • Weekends will be rotated among the four PGY2 oncology residents in an every 4th week pattern, with exceptions for training and end of year. The weekend consists of two - 8 hour shifts (Saturday and Sunday).
    • 7 weeks of weekday staffing is assigned Monday through Friday, 10 hour shifts assigned as needed
    • Two – 10 hour holiday shifts
    • Resident staffing beyond the above requirements are eligible for bonus pay (see section on bonus shifts)

Investigational Drug Service (IDS) Call for PGY2 Oncology Residents

  • Residents will be on-call during on-site staffing weekends and holidays (approximately one weekend per month).

Resident Research Project

Residents will choose a longitudinal research project at the beginning of the year, and will form a project team. Residents are required to complete the following throughout the year:

  • CITI / GCP Training
  • Pharmacy Research Committee Protocol Approval
  • IRB submission (if applicable)
  • UHC December Council meeting – Abstract and Poster
  • HOPA Annual Meeting –Abstract and Poster
  • Manuscript

Resident research project must be summarized in a written format acceptable for publication. Residents are expected to pursue publication and/or presentation of their project in a peer-review setting.

Formal Presentations

  • Major Project Poster Presentations (ex. HOPA, Vizient, local conference)
  • Two Froedtert &MCW Oncology Grand Rounds (with continuing education for pharmacists) - each presented twice for A/B weeks
  • Resident Research Project Close Out Presentation to Staff

Department Meeting Attendance

Residents are expected to be present at the meetings below that occur during learning experience time. It is acceptable to miss a meeting if patient care demands warrant; however, the situation should be communicated to the residency program director or coordinator. During clinical staffing, meeting attendance is not required. If the workload permits, residents may attend meetings at the discretion of their staffing preceptor. The resident should not schedule additional meetings during staffing shifts (ie. mentor meetings, project team meetings, etc.).

  • Weekly Oncology Residency Discussions (WORDs)
  • Weekly Hematology & Oncology Fellow’s Core Education
  • Weekly Resident Academic Half-Day Discussions – optional based on topic and past participation (internal PGY2s)
  • Monthly Oncology Pharmacy Grand Rounds

Academia Requirements

  • PGY2 Oncology Residents are required to participate in two oncology-focused student labs with MCW School of Pharmacy

Residency Mentor

  • Residency mentors are pharmacists assigned to each resident. Their primary purpose is to provide residents guidance throughout the year with an emphasis on self-assessment growth, review and provide feedback on major projects, monitor progress with residency expectations, and facilitate communication between rotations
  • Residents and mentors are expected to meet approximately monthly


  • PGY2 Residents have an active role in recruitment for incoming PGY2 Oncology pharmacy residency class
  • Responsibilities vary based on availability and scheduling, may include:
    • ASHP Personnel Placement Service Interviews
    • Networking events with candidates (i.e. ASHP residency showcase)
    • Developing interview schedules, questions, logistics
    • Coordinating, transitioning, directing on interview days
    • Candidate lunch and tours for interview days

Student Precepting Opportunities

  • May serve as primary preceptor for IPPE students, based on scheduled learning experiences
  • Assist with precepting responsibilities for APPE students during learning experiences, including longitudinal
  • Assist with precepting PGY1 residents completing oncology based learning experiences

Committee Responsibility

  • Longitudinal responsibilities: Attend and complete small projects, prepare and take minutes for each of the following committees during related longitudinal learning experiences
    • Froedtert Oncology Pharmacy & Therapeutics Subcommittee (OP&T)
    • Froedtert Oncology Pharmacy & Nursing Committee (OPNC)
    • Froedtert Molecular Tumor Board (MTB)

    PGY2 Oncology Residency Additional Opportunities

    Professional Organization Membership (Optional)

    Professional organizations offer residents additional resources and education opportunities as well as access to networking outside of Froedtert & MCW health network. Residents are highly encouraged to engage in active membership in at least one professional organization during residency and to continue to build upon membership into their careers.

    • Hematology & Oncology Pharmacy Association (HOPA)
    • American Society of Blood & Marrow Transplant (ASBMT) Pharmacy SIG
    • American Society of Health-System Pharmacists (ASHP)
    • Pharmacy Society of Wisconsin (PSW)
    • American College of Clinical Pharmacy (ACCP)

    Professional Conference Attendance (Optional)

    • Vizient Clinical Meeting (required if attending ASHP Midyear Clinical Meeting)
    • ASHP Midyear Clinical Meeting
    • Milwaukee Residency Conferences
    • BMT Tandem Annual meeting
    • Pharmacy Society of Wisconsin (PSW) Annual Meeting or Educational Conference
    • HOPA Practice Management Meeting
    • Local/Regional Oncology Pharmacy Conferences

    Formal Presentations (Optional)

    • HOPA National Journal Club Presentation
    • Oncology care support group meeting
    • Froedtert/Aurora Local Networking Journal Club
    • American Society for Transplantation and Cellular Therapy (ASTCT) Pharmacy SIG Education Committee Journal Club

    Committee Opportunities (Optional)

    • Vizient Pharmacy Cancer Care Committee
    • Froedtert Institutional Review Board Meeting - coordinate with IDS learning experience

    Academia Opportunities (Optional)

    • MCW program is considered the primary teaching certificate program.
    • Residents in PGY1 level programs interested in a teaching certificate will complete their teaching certificate through MCW
    • Teaching certificates for PGY2 level programs, as well as other academia opportunities may be pursued through CUW at discretion of program director
    • Residents can do an elective academia rotation at either CUW or MCW
    • MCW & CUW offer both block academia rotations and longitudinal academic rotations

    Past Residents

    2022 – 2023 Justin Grahl, PharmD Clinical Oncology Pharmacist, Froedtert Hospital, Milwaukee, WI
    Haylee Guerin, PharmD Clinical Oncology Pharmacist, Froedtert Hospital, Milwaukee, WI
    Ruchi Patel, PharmD Clinical Oncology Pharmacist, National Institutes of Health, Bethesda, MD
    Clare Procknow, PharmD Clinical Oncology Pharmacist, Froedtert Hospital, Milwaukee, WI
    2021 – 2022 Shelby Koppinger, PharmD Clinical Pharmacist - Oncology, Oregon Health & Science University, Portland, OR
    Emilee McCullough, PharmD Oncology Pharmacist, Mayo Clinic, Rochester, MN
    Kelli Rourke, PharmD, BCOP Ambulatory Oncology Clinical Pharmacy Specialist, Johns Hopkins Hospital, Baltimore, MD
    Emily Viehl, PharmD, BCOP Oncology Pharmacy Specialist, Yale New Haven Health, New Haven, CT
    2020 – 2021 Kate Berlin, PharmD, BCOP Malignant Hematology/BMT Clinical Pharmacy Specialist, Northwestern Medicine/Northwestern Memorial Hospital, Chicago, Ill.
    Jane McCullough, PharmD, BCOP Clinical Oncology Pharmacist, Northwestern Medicine/Northwestern Memorial Hospital, Chicago, Ill.
    Bradley Mayer, PharmD, BCOP Clinical Oncology Pharmacist, Froedtert & the Medical College of Wisconsin, Milwaukee, Wis.
    Michael Robles, PharmD, BCOP General Oncology Pharmacist, University of Washington Medicine/Seattle Cancer Care Alliance Seattle, Wash.
    2019 – 2020 Briana Amundson, PharmD, BCOP Clinical Oncology Pharmacist, Froedtert & the Medical College of Wisconsin, Milwaukee, Wis.
    Jessica McKernan, PharmD, BCOP Solid Tumor Clinical Coordinator Pharmacist in CNS/GU Clinic, Atrium Health / Carolinas Medical Center, Charlotte, N.C.
    Maggie Nelson, PharmD, BCOP Clinical Oncology Pharmacist for Bone and Marrow Transplant, University of Kansas HealthSystem, Kansas City, Kan.
    Julia Stevens, PharmD, BCOP Clinical Oncology Pharmacist, Beth Israel Deaconess Medical Center, Boston, Mass.
    2018 – 2019 Monica Chintapenta, PharmD, BCOP Clinical Specialist I - Oncology, Houston Methodist Hospital, Houston, Tex.
    Sara Harstad, PharmD, BCOP Inpatient Clinical Oncology Pharmacist- Pediatric and Adult Populations, Wilmot Cancer Institute - University of Rochester Medical Center Rochester, N.Y.
    Melika Fini, PharmD, BCOP Clinical Oncology Staff Pharmacist, Rush University Medical Center, Chicago, Ill.
    Katelyn Patterson, PharmD, BCOP Ambulatory Hematology and Oncology Pharmacist, Henry Ford Hospital - Henry Ford Health System Detroit, Mich.
    2017 – 2018 Stephanie Spitzer (Free), PharmD, BCOP Clinical Oncology Pharmacist, Froedtert Hospital & the Medical College of Wisconsin, Milwaukee, Wis.
    Cole Lightfoot, PharmD, BCOP Clinical Oncology Pharmacist, Froedtert Hospital & the Medical College of Wisconsin, Milwaukee, Wis.
    Erin McGurty, PharmD, BCOP Clinical Oncology Pharmacist, Froedtert Hospital & the Medical College of Wisconsin, Milwaukee, Wis.
    2016 – 2017 Allison Martin, PharmD, BCOP BMT Pharmacist Clinical Coordinator, Levine Cancer Institute of Carolinas HealthCare System Charlotte, NC
    Thomas Nowak, PharmD Clinical Oncology Pharmacist, Drexel Town Square, Froedtert Hospital & the Medical College of Wisconsin, Oak Creek, Wis.
    Puja Patel, PharmD, BCOP Assistant Professor, Marshall B. Ketchum University – College of Pharmacy, Fullerton, Cal.
    2015 – 2016 Nicole Zimmerman (Gunderson), PharmD Clinical Oncology Pharmacist, ThedaCare Regional Cancer Center, Appleton, Wis.
    Rachel Emerton (Pritchett), PharmD, BCOP Clinical Oncology Pharmacist, Columbus Regional Health, Columbus, Ind.
    2014 – 2015 Aaron Lorge, PharmD, BCOP Clinical Oncology Pharmacist, Froedtert Hospital & the Medical College of Wisconsin, Milwaukee Wis.
    Elizabeth Weil, PharmD, BCOP Clinical Oncology Pharmacist, Froedtert Hospital & the Medical College of Wisconsin, Milwaukee Wis.
    2013 – 2014 Danielle Gundrum (Maila), PharmD, BCOP Pharmacy Practice Faculty – Oncology, Roseman University of Health Sciences School of Pharmacy, South Jordan, Ut.
    Oncology Pharmacist, Intermountain Medical Center, Murray, Ut.
    Elizabeth Dow-Hillgartner, PharmD, BCPS, BCOP Clinical Pharmacy Specialist in Hematology/Oncology, University Hospital; UW Health, Madison, Wis.
    2012 – 2013 Melissa Rhoades (Handcock), PharmD, BCOP Clinical Oncology Pharmacist Coordinator, PGY2 Oncology Residency Program Director, Froedtert Hospital & the Medical College of Wisconsin, Milwaukee, Wis.
    2011 – 2012 Felicia Zook (Falvo), PharmD, BCOP Clinical Oncology Pharmacist, PGY2 Oncology Residency Program Coordinator, Froedtert Hospital & the Medical College of Wisconsin, Milwaukee, Wis.
    2010 – 2011 Janelle Mann, PharmD, BCOP Clinical Oncology Pharmacist, Investigational Drug Services, Washington University Infusion Center Pharmacy
    Adjunct Assistant Professor, Department of Pharmacy Practice, St. Louis College of Pharmacy, St. Louis, Mo.


Please contact our pharmacy residency program directors with any questions or concerns you may have.

Froedtert & MCW Pharmacy Residency Programs Diversity Statement

The Froedtert & MCW Pharmacy Residency Program is committed to recruiting and training pharmacists from diverse backgrounds and experiences. We value the different perspectives each resident offers. In training pharmacists as one of the most accessible members on the health care team, a diverse workforce is essential to advance the health of the patients we serve.